Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
This statistic shows the level of concern of French women about the risks related to their hormonal contraception in 2013. More than 20 percent of the women interviewed were very concerned about the risk to develop cancer, while over 15 percent of respondents were not worried at all.
Are you worried about the consequences that may be related to your contraception?
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Volume of medicines dispensed in pharmacies reimbursed in France 2014, by class
- Premium Statistic Most used contraceptive methods in Italy 2018
- Premium Statistic Key import figures of selected contraceptive products China 2023
- Premium Statistic Key export figures of selected contraceptive products in China 2023
- Premium Statistic Consumption of cancer drugs in Italy 2013-2022
- Premium Statistic Per capita expenditure on cancer drugs in Italy 2022, by region
- Premium Statistic Male contraceptive methods that young French men would be willing to use 2021
- Premium Statistic U.S. hormonal contraceptive market size from 2015 to 2026, by method
- Premium Statistic Internet usage to find information on pharmaceuticals and health in Germany 2013-2016
- Premium Statistic Italy: contraceptive use 2016 by method
About the region
10
- Premium Statistic Ranking of the reasons why women stopped taking the contraceptive pill in France 2018
- Premium Statistic Boiron laboratories turnover in France 2022, by region
- Premium Statistic Boiron laboratories turnover in 2022, by region
- Premium Statistic Net profit of Boiron laboratories 2013-2022, per share
- Premium Statistic Net investments of Boiron laboratories 2014-2022
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Premium Statistic Treatment rate for acute coronary syndrome France 2018, by region
- Premium Statistic Anxiolytics: expenses of French health insurance 2018
- Premium Statistic Number of people treated for PAD in France 2018, by age
- Premium Statistic Rate of men treated for sequelae of stroke in France 2018, by age
Other regions
10
- Basic Statistic Number of users of hypertension medicine in Sweden 2023, by age and gender
- Premium Statistic Hormonal contraceptive monthly import value in China 2022-2024
- Basic Statistic Active drug shortages in the U.S. in leading therapeutic classes June 2023
- Premium Statistic Net sales of drugs in pharmacies in Spain 2012-2022
- Premium Statistic Top indications for new indication approvals in Canada 2018
- Premium Statistic Married women contraceptive practice South Korea 2012, by method
- Premium Statistic Genitourinary system & sexual hormones market revenue in Argentina 2017-2022
- Premium Statistic Bolivia: hormones imports 2014-2017
- Premium Statistic El Salvador: antibiotic exports 2014-2017
- Premium Statistic Panama: vitamins import value 2017, by country
Related statistics
10
- Premium Statistic Boiron laboratories' European turnover in 2022, by country
- Premium Statistic Turnover of Boiron laboratories in North America 2022, by country
- Premium Statistic Global turnover of Boiron laboratories 2012-2022
- Premium Statistic Share capital of Boiron laboratories 2012-2022
- Premium Statistic Turnover of the nonproprietary drugs segment of Boiron in 2022, by region
- Premium Statistic Turnover of Boiron laboratories abroad 2012-2022
- Premium Statistic Global turnover of Boiron's specialties segment 2022, by region
- Premium Statistic EBITDA of Boiron laboratories 2012-2022
- Premium Statistic Boiron's stock price at the end of the year 2012-2022
- Premium Statistic Income after tax, profit-sharing, amortizations and reserves of Boiron 2022
Further related statistics
10
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co total assets 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Popularity of walking for fitness in the U.S. 2010-2023
- Leading causes of death among the white population in the United States in 2020
- Leading causes of death among Black U.S. residents in 2020
- U.S. population without health care visits 1997-2018, by gender
- Adults with severe headache or migraine 1997-2016, by gender
- Leading European medtech countries based on market capitalization 2014
Further Content: You might find this interesting as well
Statistics
- MorphoSys' research & development expenditure 2006-2023
- Merck & Co total assets 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Popularity of walking for fitness in the U.S. 2010-2023
- Leading causes of death among the white population in the United States in 2020
- Leading causes of death among Black U.S. residents in 2020
- U.S. population without health care visits 1997-2018, by gender
- Adults with severe headache or migraine 1997-2016, by gender
- Leading European medtech countries based on market capitalization 2014
Harris Interactive, & Grazia. (February 8, 2013). Are you worried about the consequences that may be related to your contraception? [Graph]. In Statista. Retrieved May 11, 2024, from https://www.statista.com/statistics/766717/level-concern-francaises-risks-contraception-hormonal/
Harris Interactive, und Grazia. "Are you worried about the consequences that may be related to your contraception?." Chart. February 8, 2013. Statista. Accessed May 11, 2024. https://www.statista.com/statistics/766717/level-concern-francaises-risks-contraception-hormonal/
Harris Interactive, Grazia. (2013). Are you worried about the consequences that may be related to your contraception?. Statista. Statista Inc.. Accessed: May 11, 2024. https://www.statista.com/statistics/766717/level-concern-francaises-risks-contraception-hormonal/
Harris Interactive, and Grazia. "Are You Worried about The Consequences That May Be Related to Your Contraception?." Statista, Statista Inc., 8 Feb 2013, https://www.statista.com/statistics/766717/level-concern-francaises-risks-contraception-hormonal/
Harris Interactive & Grazia, Are you worried about the consequences that may be related to your contraception? Statista, https://www.statista.com/statistics/766717/level-concern-francaises-risks-contraception-hormonal/ (last visited May 11, 2024)
Are you worried about the consequences that may be related to your contraception? [Graph], Harris Interactive, & Grazia, February 8, 2013. [Online]. Available: https://www.statista.com/statistics/766717/level-concern-francaises-risks-contraception-hormonal/